Q-Pharm Pty Limited commenced operations as a specialised clinical trial provider on 1^st July 2002. 

Initially the company conducted predominantly bioequivalence studies, but over the intervening years has developed skills and experience in a wide variety of Phase 1 trials.  

The core business today is first-time-in-humans studies, pharmacokinetic studies supporting both new molecule development and reformulation of established drugs and vaccine studies.  We remain the major providers of bioequivalence studies in Australia .

Q-Pharm is a private company, comprising of a joint venture between The University of Queensland (one of Australia ’s leading research-intensive universities) the Queensland Institute of Medical Research ( Australia ’s largest medical research institute) and some private investors.